"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat

Circulation
Y BlaauwM A Allessie

Abstract

Currently available antiarrhythmic drugs are only moderately effective against atrial fibrillation (AF) and may cause ventricular proarrhythmia. AVE0118 is a blocker of atrium-specific early K+ currents (I(Kur)/I(to)). Effects of intravenous AVE0118 and dofetilide on atrial effective refractory period (AERP) and inducibility of AF were measured before and after 48-hours of AF-induced electrical remodeling in the goat. During persistent AF (53+/-19 days), the cardioversion efficacy and effects on atrial wavelength of AVE0118, dofetilide, and ibutilide were evaluated. QT durations were measured during atrial pacing and persistent AF. After 48 hours of AF, the effect of dofetilide on AERP was reduced, and induction of AF was not prevented. In contrast, the class III action of AVE0118 was enhanced, and AF inducibility decreased from 100% to 32% (P<0.001). At 1, 3, and 10 mg x kg(-1) x h(-1), AVE0118 terminated persistent AF in 1 of 8, 3 of 8, and 5 of 8 goats, respectively. Dofetilide and ibutilide terminated AF in 1 of 5 and 2 of 7 goats. AVE0118 0.5, 1.5, and 5 mg/kg prolonged the AERP during AF and increased the fibrillation wavelength from 6.7+/-0.6 to 8.5+/-0.5, 9.7+/-0.5, and 11.2+/-0.9 cm (P<0.01). Whereas dofetilide and ibu...Continue Reading

References

Jul 1, 1996·Journal of the American College of Cardiology·K A EllenbogenJ T Vanderlugt
May 10, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Hidehiko NagasawaHiroshi Inoue
Jun 14, 2002·Cardiovascular Research·Ralph F Bosch, Stanley Nattel
Dec 31, 2002·Journal of the American College of Cardiology·Hung-Fat Tse, Chu-Pak Lau
Nov 14, 2003·Cardiovascular Research·Klaus J WirthMarkus Bleich

❮ Previous
Next ❯

Citations

Oct 31, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·H-J SchneiderA Luchner
Jul 9, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·F FischerE P Scholz
Jun 21, 2006·Herzschrittmachertherapie & Elektrophysiologie·U RavensD Dobrev
Sep 24, 2005·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Akiko Shiroshita-TakeshitaStanley Nattel
Mar 7, 2007·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Samuel Lévy
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Robert G TielemanHarry J G M Crijns
Mar 8, 2005·Trends in Pharmacological Sciences·Eva DelpónJuan Tamargo
Nov 3, 2005·Nature Reviews. Drug Discovery·Richard L Page, Dan M Roden
Dec 2, 2006·Nature Reviews. Drug Discovery·Stanley Nattel, Leif Carlsson
Mar 31, 2012·Nature Reviews. Drug Discovery·Dobromir DobrevStanley Nattel
Dec 17, 2010·Cardiovascular Research·Ursula Ravens, Erich Wettwer
Aug 5, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Sang-Ho KooTae-Joon Cha
Apr 18, 2007·Journal of Cardiovascular Pharmacology·Klaus J WirthHeinz Gögelein
Aug 2, 2008·Journal of Cardiovascular Pharmacology·Joachim R Ehrlich
Sep 23, 2008·Journal of Cardiovascular Pharmacology·Gerald V Naccarelli, Mario D Gonzalez
Aug 2, 2008·Journal of Cardiovascular Pharmacology·Alexander Burashnikov, Charles Antzelevitch
Mar 1, 2012·Journal of Cardiovascular Pharmacology·Alexander BurashnikovCharles Antzelevitch
Sep 24, 2010·American Journal of Therapeutics·Sony JacobNicholas Z Kerin
Nov 7, 2008·Clinical and Experimental Pharmacology & Physiology·Lan YangDan-Na Tu
Jul 13, 2006·Molecular Pharmacology·Niels DecherMichael C Sanguinetti
Dec 27, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Carlos SánchezBlanca Rodríguez
Mar 2, 2013·Circulation Research·Sandeep V Pandit, José Jalife
Jun 17, 2008·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yoshihiro Hashimoto
Feb 16, 2010·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Toru Yamashita
Jun 5, 2010·Indian Journal of Pharmacology·J Singh, J S Braich
Sep 1, 2006·Future Cardiology·Simone MuscoPeter R Kowey
Feb 25, 2010·Nature Reviews. Cardiology·Alexander Burashnikov, Charles Antzelevitch
Jun 7, 2006·Current Opinion in Cardiology·Dawood Darbar, Dan M Roden
Aug 24, 2010·Expert Opinion on Therapeutic Patents·Neil A Castle
Jul 4, 2007·Expert Review of Cardiovascular Therapy·Gerald V NaccarelliMario D Gonzalez
May 1, 2010·Expert Review of Clinical Pharmacology·Andrew Tinker, Stephen C Harmer
Jan 1, 2010·Expert Opinion on Drug Discovery·Hirofumi RokutanJochen Springer
Apr 2, 2009·Expert Opinion on Investigational Drugs·Juan TamargoEva Delpón
Apr 2, 2008·Expert Opinion on Pharmacotherapy·Sabine JankoEllen Hoffmann
Jan 25, 2007·Expert Opinion on Investigational Drugs·Kristen K Patton, Richard L Page
May 31, 2006·Expert Opinion on Pharmacotherapy·Panos E Vardas, Eleftherios M Kallergis
May 27, 2009·Expert Opinion on Emerging Drugs·Alexander Burashnikov, Charles Antzelevitch
Mar 13, 2009·Expert Opinion on Investigational Drugs·Mohan N Viswanathan, Richard L Page
Dec 21, 2010·Annals of Medicine·Pasquale SantangeliAndrea Natale
Mar 19, 2014·Current Opinion in Pharmacology·Erich Wettwer, Heinrich Terlau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.